Growth Metrics

LivaNova (LIVN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for LivaNova (LIVN) over the last 12 years, with Q3 2025 value amounting to $112.9 million.

  • LivaNova's Cost of Revenue rose 1628.06% to $112.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $434.5 million, marking a year-over-year increase of 154.46%. This contributed to the annual value of $400.0 million for FY2024, which is 56.02% up from last year.
  • Per LivaNova's latest filing, its Cost of Revenue stood at $112.9 million for Q3 2025, which was up 1628.06% from $113.5 million recorded in Q2 2025.
  • LivaNova's 5-year Cost of Revenue high stood at $135.4 million for Q4 2023, and its period low was $68.4 million during Q4 2021.
  • In the last 5 years, LivaNova's Cost of Revenue had a median value of $91.4 million in 2022 and averaged $93.1 million.
  • In the last 5 years, LivaNova's Cost of Revenue crashed by 3508.38% in 2021 and then surged by 4820.43% in 2023.
  • Quarter analysis of 5 years shows LivaNova's Cost of Revenue stood at $68.4 million in 2021, then surged by 33.52% to $91.4 million in 2022, then soared by 48.2% to $135.4 million in 2023, then fell by 20.63% to $107.5 million in 2024, then increased by 5.06% to $112.9 million in 2025.
  • Its Cost of Revenue was $112.9 million in Q3 2025, compared to $113.5 million in Q2 2025 and $100.6 million in Q1 2025.